The correlation of atrial fibrillation and serum electrolyte level changes after coronary artery bypass grafting surgery

ISRCTN ISRCTN36486884
DOI https://doi.org/10.1186/ISRCTN36486884
Protocol serial number N/A
Sponsor Kaunas Medical University, Institute for Biomedical Research (Lithuania)
Funder Support was provided from departmental sources: Department of Anaesthesiology and Intensive Care, Clinic of Cardiac Surgery, Heart Center, Kaunas Medical University, Lithuania
Submission date
24/12/2005
Registration date
05/01/2006
Last edited
25/09/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Edmundas Sirvinskas
Scientific

Eiveniu 2
Kaunas
3000
Lithuania

Email esirvinskas@yahoo.com

Study information

Primary study designInterventional
Study designRandomized placebo-controlled trial
Secondary study designRandomised controlled trial
Scientific title
Study objectivesSerum electrolyte level changes can influence the incidence of atrial fibrillation
Ethics approval(s)Approval of Kaunas Region Ethics Committee for Biomedical Research No. 89/2003
Health condition(s) or problem(s) studiedAtrial fibrillation and serum electrolyte balance disorders
InterventionMagnesium sulfate infusion versus normal saline as placebo infusion
Intervention typeDrug
PhaseNot Specified
Drug / device / biological / vaccine name(s)Magnesium sulphate
Primary outcome measure(s)

The incidence of atrial fibrillation in both groups

Key secondary outcome measure(s)

Correlation between serum electrolyte balance and incidence of atrial fibrillation

Completion date30/05/2005

Eligibility

Participant type(s)Patient
Age groupAdult
SexMale
Target sample size at registration165
Key inclusion criteria1. Men undergoing elective coronary artery bypass grafting for ischemic heart disease
2. Serum electrolyte leves within normal ranges
3. No diabetes, pulmonary, liver and renal disfunction disease
4. Sinus rhythm before the surgey
5. No atrial fibrillation in the past
Key exclusion criteria1. Excessive bleeding after the surgery
2. The need of electric heart stimulation after the surgery
3. The need of vasoactive agents after the surgery
Date of first enrolment01/01/2004
Date of final enrolment30/05/2005

Locations

Countries of recruitment

  • Lithuania

Study participating centre

Eiveniu 2
Kaunas
3000
Lithuania

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan